Lp-PLA2 may be a vital factor in the process of NAFLD, more studies could further explore the mechanism of Lp-PLA2 and ensure its potential as a therapeutic target in NAFLD. The gene discussed is PLA2G7; the disease is metabolic dysfunction-associated steatotic liver disease.